X
<

Crude Oil Tanker Stocks: Estimates, Recommendations for 2Q17

PART:
1 2 3 4 5 6 7 8 9 10 11
Part 7
Crude Oil Tanker Stocks: Estimates, Recommendations for 2Q17 PART 7 OF 11

What Analysts Are Saying about Frontline’s Upcoming 2Q17 Results

Stock performance

Most crude oil tanker stocks haven’t had a good year so far. Frontline (FRO) is no exception. FRO stock hit a fresh 52-day low of $5.35 on June 20, 2017. As of July 6, 2017, the stock has fallen 18.9% since the start of the year. Let’s see what analysts have to say about Frontline’s upcoming 2Q17 results.

What Analysts Are Saying about Frontline’s Upcoming 2Q17 Results

Interested in FRO? Don't miss the next report.

Receive e-mail alerts for new research on FRO

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Revenue and earnings estimates

Wall Street analysts estimate that Frontline’s revenue will be ~$103.0 million in the second quarter compared to $177.1 million in 1Q17 and ~$191.0 million in 2Q16. Since revenue is expected to be lower, EBITDA (earnings before interest, tax, depreciation, and amortization) is also estimated to be lower. Analysts expect 2Q17 EBITDA to be $55.0 million compared to $76.0 million in 1Q17 and $72.0 million in 2Q16.

For 2017, analysts expect Frontline’s revenue to be $522.0 million, which is 30.8% lower than its 2016 revenue of $754.0 million. FRO’s 2017 EBITDA estimate stands at $245.0 million, which is lower than EBITDA of $271.0 million in 2016.

Consensus rating

According to Reuters, the consensus rating for Frontline is 2.8, which means a “hold.” Below are the consensus ratings for other crude oil tanker companies:

  • Teekay Tankers (TNK): 2.9, or a “hold”
  • Euronav (EURN): 2.2, or a “buy”
  • Nordic American Tankers (NAT): 3.9, or a “sell”
  • Gener8 Maritime (GNRT): 2.0, or a “buy”

Analyst recommendations

Six analysts have given recommendations for Frontline. None of those analysts have recommended a “strong buy” for the stock. One analyst has recommended a “buy.” Five have given it a “hold,” and none of them have given it a “sell” or “strong sell.”

The 12-month consensus target price is $6.50, which implies a potential upside of 14.2% compared to the market price of $5.70 on July 6, 2017.

X

Please select a profession that best describes you: